<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="tbl6" position="float">
 <label>Table 6</label>
 <caption>
  <title>Inhibitors with Other Targets against SARS-CoV
   <xref rid="t6fn1" ref-type="table-fn">a</xref>
  </title>
 </caption>
 <table frame="hsides" rules="groups" border="0">
  <colgroup>
   <col align="left"/>
   <col align="left"/>
   <col align="left"/>
   <col align="left"/>
   <col align="left"/>
   <col align="left"/>
   <col align="left"/>
   <col align="left"/>
  </colgroup>
  <thead>
   <tr>
    <th style="border:none;" align="center"> </th>
    <th style="border:none;" align="center">compd</th>
    <th style="border:none;" align="center">reported mechanism of action</th>
    <th style="border:none;" align="center">IC
     <sub>50</sub> (μM)
    </th>
    <th style="border:none;" align="center">CC (μM)</th>
    <th style="border:none;" align="center">SI</th>
    <th style="border:none;" align="center">CoV type</th>
    <th style="border:none;" align="center">ref</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td style="border:none;" align="left">
     <bold>45</bold>
    </td>
    <td style="border:none;" align="left">K11777</td>
    <td rowspan="3" style="border:none;" align="left">Targets cathepsin-mediated cell entry and the endosomal proteolysis.</td>
    <td style="border:none;" align="left">3.2 × 10
     <sup>–4</sup>
    </td>
    <td rowspan="3" style="border:none;" align="left">NT</td>
    <td rowspan="3" style="border:none;" align="left">NT</td>
    <td rowspan="3" style="border:none;" align="left">SARS-CoV</td>
    <td rowspan="3" style="border:none;" align="left">Zhou et al.
     <sup>
      <xref ref-type="bibr" rid="ref77">77</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">
     <bold>46</bold>
    </td>
    <td style="border:none;" align="left">SMDC256159</td>
    <td style="border:none;" align="left">7.0 × 10
     <sup>–5</sup>
    </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">
     <bold>47</bold>
    </td>
    <td style="border:none;" align="left">SMDC256160</td>
    <td style="border:none;" align="left">8.0 × 10
     <sup>–5</sup>
    </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">
     <bold>48</bold>
    </td>
    <td style="border:none;" align="left">Nitazoxanide</td>
    <td style="border:none;" align="left">Induces the host innate immune response to produce IFNs.</td>
    <td style="border:none;" align="left">2.12</td>
    <td style="border:none;" align="left">&gt;35.5</td>
    <td style="border:none;" align="left">&gt;16.7</td>
    <td rowspan="3" style="border:none;" align="left">SARS-CoV-2</td>
    <td rowspan="3" style="border:none;" align="left">Wang et al.
     <sup>
      <xref ref-type="bibr" rid="ref16">16</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">
     <bold>49</bold>
    </td>
    <td style="border:none;" align="left">Nafamostat</td>
    <td style="border:none;" align="left">Inhibits S protein-mediated membrane fusion.</td>
    <td style="border:none;" align="left">22.5</td>
    <td style="border:none;" align="left">&gt;100</td>
    <td style="border:none;" align="left">&gt;4.4</td>
   </tr>
   <tr>
    <td style="border:none;" align="left">
     <bold>50</bold>
    </td>
    <td style="border:none;" align="left">Penciclovir</td>
    <td style="border:none;" align="left">Inhibits RdRp.</td>
    <td style="border:none;" align="left">95.9</td>
    <td style="border:none;" align="left">&gt;400</td>
    <td style="border:none;" align="left">&gt;4.2</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn id="t6fn1">
   <label>a</label>
   <p>NT, not tested.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
